Navigation Links
NovaRx Corporation Announces FDA Approval of Protocol Amendment to Special Protocol Assessment (SPA) for Phase III Lucanix(R) Study in Non-Small Cell Lung Cancer (NSCLC)
Date:11/4/2009

cine approach. NovaRx is in discussions with the FDA to initiate a clinical trial for one of its promising pipeline vaccines, Glionix(TM), for the treatment of brain cancer. A version of this vaccine has already been tested in patients with provocative results.

CONTACT: Carissa Schumacher for NovaRx Corporation at +1-310-499-8970 or novarx@novarx.com

SOURCE NovaRx Corporation


'/>"/>
SOURCE NovaRx Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Amerigroup Corporation to Present at the 18th Annual Credit Suisse Healthcare Conference on November 12
2. MDS Inc. and Danaher Corporation Receive Second Request for Information from U.S. Federal Trade Commission for MDS Analytical Technologies Sale
3. Triple-S Management Corporation Reports Third Quarter 2009 Results
4. Service Corporation International Announces Schedule for Its Third Quarter 2009 Earnings Release and Conference Call
5. COMFORCE Corporation to Hold Conference Call to Discuss Third Quarter 2009 Results
6. Addus HomeCare Corporation Prices Initial Public Offering
7. Zix Corporation Hits High End of Financial Guidance as Company Announces Third Quarter 2009 Financial Results
8. HLTH Corporation Announces Completion of Sale of Porex Unit to Aurora Capital Group
9. China Medicine Corporations Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan
10. Micro-Waste Corporation Ordered to Pay Sanitecs Attorney Fees
11. Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...hursday, Dec. 3 ,, Head of Army,s Warrior Tra...my Wounded Warriors; Army Embraces Reality of ,Uns...TON, Dec. 2 The followi... on Disability: ,, WHAT: Wounded veterans and...AW2) program,s National Organization on Disability...
(Date:12/2/2009)...OND, Wash., Dec. 2 /PRNewswire/ -- Golden Livi...l collaborate to give caregivers single-point acce... for providing ongoing care after patients leave t...s better tools for managing patients, health. ,...ization to adopt Microsoft Amalga Unified Intellig...
(Date:12/2/2009)...ec. 2 Watson Pharmaceuti...has completed the acquisition of Arrow Group for a...es a financially strong, global specialty pharmace...nues and operations in more than 20 countries. ,...son shareholders as a result of this financially s...
(Date:12/2/2009)...h from TB, not Addison,s, researcher says , ...oman behind Pride and Prejudice and Emma may ...sease, as has long been believed, says one British...t the age of 41, many historians and other experts...ich affects the adrenal glands and creates problem...
(Date:12/2/2009)... per week prior to pregnancy increased risk by 22%...-- Women who drink five or more servings of sugar-...ase their risk of developing diabetes during pregn...s have shown an association with other chronic met..., an assistant professor of epidemiology at Louisi...
Breaking Medicine News(10 mins):Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 2Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 3Health News:Golden Living Kick-Starts Post-Acute Health IT with Microsoft HealthVault and Amalga UIS Connection 4Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5Health News:New Light on Jane Austen's Final Chapter 2Health News:Sugary Colas Tied to Gestational Diabetes 2Health News:Sugary Colas Tied to Gestational Diabetes 3
...c. 7 Transcept Pharmaceuticals,Inc. today announc...tive,Officer, will participate in an expert panel ...the RBC Capital Markets 2007 Healthcare Conference...Ken Trbovich, Vice,President, Capital Markets at R...
... Ventures, a health and life,sciences focused vent...fel,has been named Partner of the firm., "We are ...d Jordan,Davis, Managing Partner of Radius. "David...op Radius into a leading,health and life sciences ...
...f the commonest surgical procedures performed on m... cause both physical and psychological harm, while...lly beneficial. Two doctors debate the issue in th...ked throughout the world, long after female circum...
...ts charters is inadequate and should be replaced w... expert in this weeks BMJ. , But even these raise... associate at LSE Health. , The British Medical A... expect from the NHS. , Although it lacked detai...
...c 7 Bond,Laboratories, Inc. (OTC Bulletin Board: ...t the company intends to file with the NASD to imp...s., Bond Laboratories, Inc. shareholders as of th...stock split will own,10,000 shares following the s...
...H BRUNSWICK, New Jersey, December 7, Rosetta Genom...ent of microRNA-based diagnostics and therapeutics...l Head of R&D at Rosetta Genomics,will present at ...presentation will be available on the,"Investors" ...
Other Medicine News:Health News:Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference 2Health News:Is infant male circumcision an abuse of the rights of the child? 2Health News:Concept of patients' charters 'inadequate' 2Health News:Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference 2
(Date:12/2/2009)..., , ROYAL OAK, Mich., Dec. 2 /PRNewswir...ess security company today announced the exclusiv...urity monitors. Designed to look like a piece of j...have a critical function; immediate emergency medi....newscom.com/cgi-bin/prnh/20091202/DE19790 ) ,...
(Date:12/2/2009)..., , KNOXVILLE, Tenn., Dec. 2 /PRNewsw...logy.com ), a division of the nation,s largest pro...unced it has signed two contracts to provide teler... and Illinois. ,, An agreement signed with UpSt...., will allow TeamHealth Teleradiology to provide ...
(Date:12/2/2009)..., , PHILADELPHIA, Pennsylvania, Dece...HP, NASDAQ: SHPGY ), the global specialty biophar...the litigation with Teva,Pharmaceuticals USA, Inc....ized generic version of ADDERALL XR. Shire has bee...XR since April 1, 2009. Shire,s ability to supply,...
Breaking Medicine Technology:TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2Caliper Life Sciences Third Quarter 2009 Financial Results Conference Call Notice 59856 1Caliper Life Sciences Third Quarter 2009 Financial Results Conference Call Notice 59856 2Epeius Biotechnologies to Partner at BIO Investor Forum 14548 1Epeius Biotechnologies to Partner at BIO Investor Forum 14548 2Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 1Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 2Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 3Pulmo BioTech Inc Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind 28TM 29 5618 4
...N.C., Oct. 16 Liquidia,Technologies announces a s...nd University of North Carolina-Chapel Hill profes...all, Dr. DeSimone will discuss drug delivery,appli...research in cancer,therapeutics. (Logo: http://...), -- Prostate Cancer Foundation Scientific Retre...
... following was,released today by Trust for America...to discuss a new report from the,American Academy ... (TFAH),"Pandemic Influenza: Warning, Children At-...ness in treating and caring for children during a ...endations from AAP and TFAH for,how to address tho...
Other Medicine Technology:Targeted Nanoparticles Offer Promise in the Battle Against Cancer 2
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: